Digital Media briefs: April 2014

Share this article:
Digital Media briefs: April 2014
Digital Media briefs: April 2014

A report published by the Journal of the American Medical Association shows that the patient-as-consumer perspective is playing out in doctors' offices. The findings from 2,137 patients found that almost 60% considered doctor rating sites “somewhat important” when they chose a doctor, trailing first-hand recommendations. Researchers found that bad medical reviews kept away 37% of the surveyed patients who used physician-scoring services, while good reviews pulled in 35% of respondents who used review sites.

The National Multiple Sclerosis Society's website has been revamped. The now mobile-friendly site includes new features such as a “my profile” section that lets users set preferences and track their site activity, and a user experience that makes it easier to read and more accessible for users who rely on devices like screen readers.

The FDA's OpenFDA Twitter feed has 186 Twitter followers and six official Tweets as of this writing. The Twitter feed, along with a related website, launched February 27. The agency says its goal is to be “a valuable resource to those wishing to use public FDA data in both the public and private sector.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?